ALACHUA, Fla., May 24 /PRNewswire-FirstCall/ -- Oragenics, Inc. (AMEX:ONI) announced today that Robert T. Zahradnik, Ph.D., president and chief executive officer, will be presenting at the Dutton Associates' Health Sciences Small Cap Conference on May 31, 2006 at 11:20 am PT/2:20 pm ET at The St. Regis Hotel, San Francisco, California. Dr. Zahradnik will present a company overview.
The presentation will be webcast and made available through August 20, 2006 at http://www.duttonassociates.com/ .
About Oragenics Oragenics, Inc. is a biopharmaceutical company with a pipeline of proprietary technologies. The Company has a number of products in discovery, preclinical and clinical development, with a concentration in two main therapeutic areas: infectious disease and oncology. Oragenics' core pipeline includes products for use in the treatment of dental and periodontal infectious diseases, systemic bacterial infections and obesity. In the discovery stage are three platform technologies for identifying biomarkers of infection, cancer and autoimmune diseases and for the solid state synthesis of bioactive peptides including small molecule antibiotics. For additional information about Oragenics, please visit our website: http://www.oragenics.com/ . DATASOURCE: Oragenics, Inc.
CONTACT: Robert T. Zahradnik, Oragenics, Inc., +1-386-418-4018, ext.
222 Web site: http://www.oragenics.com/
|